Jon Pritko News Today

A trade show, a boat show and a boating-and-fishing showcase at a college football game are signals that our industry is tracking strong.

Johnson & Johnson says late-stage COVID vaccine trial fully enrolled Johnson & Johnson said on Thursday it has fully enrolled participants for the first late-stage trial of its COVID-19 single-dose vaccine candidate. The study, named Ensemble, has enrolled about 45,000 participants and is being conducted by its unit Janssen, J&J said here in a statement, adding that it expects interim data from the trial by the end of January 2021. J&J also said it plans to submit an emergency use authorizatio...